Learn More
Medchemexpress LLC Norvancomycin (monohydrochloride) | 213997-73-0 | 95.3% | 1 ML

Supplier: Medchemexpress LLC HYB192410MM/1ML
Norvancomycin monohydrochloride is a cell wall synthesis inhibitor, targeting peptidoglycan precursors of Gram-positive bacteria. It irreversibly inhibits bacterial cell wall synthesis, showing antibacterial activity. Primarily used for Gram-positive bacterial infections like MRSA and MRSE, it can also be incorporated into bionic calcium phosphate coatings on titanium implants to enhance antibacterial activity and prevent postoperative orthopedic infections.
- Targets peptidoglycan precursors of Gram-positive bacteria
- Cannot pass the blood-brain barrier
- Inhibits bacterial cell wall synthesis
- Effective against Gram-positive bacterial infections (MRSA, MRSE)
- Enhances antibacterial activity in titanium implant coatings
- Inhibits Staphylococcus aureus in in vitro studies
- Widely distributed in rat tissues (not in brain)
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.